Concepedia

Anne‐Sophie Alary

AA

Statistics

Publications

10

Citations

307

H-Index

10

Active since

2015

Affiliations

Centre National de la Recherche Scientifique(Current)

Inserm

Assistance Publique – Hôpitaux de Paris

Université Paris Cité

Institut Paoli-Calmettes

Anne‐Sophie Alary is an author at Centre National de la Recherche Scientifique specializing in medicine, hematology, and hematopathology.

ORCID

Publications per year

2015–2025

10

Publications

10

A variant erythroferrone disrupts iron homeostasis in <i>SF3B1</i> -mutated myelodysplastic syndrome

Sabrina Bondu, Anne‐Sophie Alary, Carine Lefèvre et al. · Science Translational Medicine · 2019 · 80 citations · Full text

, , +17

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients

Sylvain Garciaz, Anne‐Sophie Alary, Colombe Saillard et al. · Cancers · 2022 · 59 citations · Full text

, , +14

Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX

Vincent Jachiet, Olivier Kosmider, Maxime Beydon et al. · Blood · 2025 · 31 citations · Full text

, , +13

Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes

Sophie Park, Olivier Kosmider, Frédéric Maloisel et al. · Haematologica · 2018 · 24 citations · Full text

, , +17

RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia

Justine Decroocq, Rudy Birsen, Camille Montersino et al. · Leukemia · 2022 · 24 citations · Full text

, , +14

1–5 of 10